Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung

American Journal of Respiratory Cell and Molecular Biology

Volumn 43, Issue 4, 2010, Pages 394-402

  Sammani, Saad ^a   Moreno Vinasco, Liliana ^a   Mirzapoiazova, Tamara ^a   Singleton, Patrick A ^a   Chiang, Eddie T ^a   Evenoski, Carrie L ^a   Wang, Ting ^a   Mathew, Biji ^a   Husain, Aliya ^b   Moitra, Jaideep ^a   Sun, Xiaoguang ^a   Nunez, Luis ^a   Jacobson, Jeffrey R ^a   Dudek, Steven M ^a   Natarajan, Viswanathan ^a   Garcia, Joe G N ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

LPS; Lung edema; S1P; SB 649146; SEW 2871

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; SB 649146; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE; OXADIAZOLE DERIVATIVE; THIOPHENE DERIVATIVE;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CAPILLARY PERMEABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; GENE DELETION; GENE EXPRESSION; GENE SILENCING; KNOCKOUT MOUSE; LETHALITY; LUNG; LUNG ALVEOLUS; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; ACUTE LUNG INJURY; ANIMAL; BODY FLUID; C57BL MOUSE; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG POTENTIATION; INVERSE AGONISM; LUNG GAS EXCHANGE; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; VASCULARIZATION;

MURINAE; MUS;

ACUTE LUNG INJURY; ANIMALS; BLOOD-AIR BARRIER; BODY FLUIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG INVERSE AGONISM; GENE DELETION; GENE SILENCING; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXADIAZOLES; RECEPTORS, LYSOSPHINGOLIPID; THIOPHENES;

EID: 77952327561     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0223OC     Document Type: Article

References (46)

1. Brower RG. Mechanical ventilation in acute lung injury and ARDS: tidal volume reduction. Crit Care Clin 2002;18:1-13. (Pubitemid 34226465)
2. Goss CH, Brower RG, Hudson LD, Rubenfeld GD. Incidence of acute lung injury in the United States. Crit Care Med 2003;31:1607-1611.
3. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, Floros J, Gimbrone MA Jr, Hoffman E, Hubmayr RD, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003;167:1027-1035.
4. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998;157:294-323. (Pubitemid 28071297)
5. Carlton DP, Cummings JJ, Scheerer RG, Poulain FR, Bland RD. Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol 1990;69:577-583.
6. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988;137:1159-1164.
7. Parker JC, Hernandez LA, Longenecker GL, Peevy K, Johnson W. Lung edema caused by high peak inspiratory pressures in dogs: role of increased microvascular filtration pressure and permeability. Am Rev Respir Dis 1990;142:321-328. (Pubitemid 20235938)
8. Parker JC, Hernandez LA, Peevy KJ. Mechanisms of ventilator-induced lung injury. Crit Care Med 1993;21:131-143.
9. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamburg JR, English D. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by EDG-dependent cytoskeletal rearrangement. J Clin Invest 2001;108:689-701.
10. Dudek SM, Jacobson JR, Chiang ET, Birukov KG, Wang P, Zhan X, Garcia JG. Pulmonary endothelial cell barrier enhancement by sphingosine 1-phosphate: roles for cortactin and myosin light chain kinase. J Biol Chem 2004;279:24692-24700.
11. Singleton PA, Dudek SM, Chiang ET, Garcia JG. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, Pi3 kinase, Tiam1/ Rac1, and alpha-actinin. FASEB J 2005;19:1646-1656.
12. Singleton PA, Dudek SM, Ma SF, Garcia JG. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation: novel role for hyaluronan and CD44 receptor family. J Biol Chem 2006;281:34381-34393.
13. Schaphorst KL, Chiang E, Jacobs KN, Zaiman A, Natarajan V, Wigley F, Garcia JG. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 2003;285:L258-L267. (Pubitemid 36736489)
14. McVerry BJ, Peng X, Hassoun PM, Sammani S, Simon BA, Garcia JG. Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 2004;170: 987-993.
15. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM, Garcia JG. Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 2004;169:1245-1251. (Pubitemid 38680403)
16. Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006;355: 1124-1140.
17. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem 2003;278:47281-47290.
18. Moreno-Vinasco L, Jacobson JR, Bonde P, Sammani S, Mirzapoiazova T, Vigneswaran WT, Garcia JG. Attenuation of rodent lung ischemiareperfusion injury by sphingosine 1-phosphate. J Organ Dysfunction 2008;4:106-114. (Pubitemid 351882475)
19. Hla T. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 2004;15:513-520.
20. Liu F, Verin AD, Wang P, Day R, Wersto RP, Chrest FJ, English DK, Garcia JG. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis: involvement of G (ialpha2)-linked Rho kinase activity. Am J Respir Cell Mol Biol 2001;24:711-719.
21. Rosen H, Goetzl EJ. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat Rev Immunol 2005;5:560-570. (Pubitemid 40961333)
22. Nonas SA, Moreno-Vinasco L, Ma SF, Jacobson JR, Desai AA, Dudek SM, Flores C, Hassoun PM, Sam L, Ye SQ, et al. Use of consomic rats for genomic insights into ventilator-associated lung injury. Am J Physiol Lung Cell Mol Physiol 2007;293:L292-L302.
23. Wang T, Moreno-Vinasco L, Huang Y, Lang GD, Linares JD, Goonewardena SN, Grabavoy A, Samet JM, Geyh AS, Breysse PN, et al. Murine lung responses to ambient particulate matter: genomic analysis and influence on airway hyperresponsiveness. Environ Health Perspect 2008;116: 1500-1508.
24. Mirzapoiazova T, Kolosova IA, Moreno L, Sammani S, Garcia JG, Verin AD. Suppression of endotoxin-induced inflammation by taxol. Eur Respir J 2007;30:429-435.
25. Moitra J, Evenoski C, Sammani S, Wadgaonkar R, Turner JR, Ma SF, Garcia JG. A transgenic mouse with vascular endothelial overexpression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age. Transl Res 2008;151:141-153.
26. Meyer NJ, Huang Y, Singleton PA, Sammani S, Moitra J, Evenoski CL, Husain AN, Mitra S, Moreno-Vinasco L, Jacobson JR, et al. Gadd45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling. FASEB J 2009;23:1325-1333.
27. Waters CM, Long J, Gorshkova I, Fujiwara Y, Connell M, Belmonte KE, Tigyi G, Natarajan V, Pyne S, Pyne NJ. Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. FASEB J 2006;20: 509-511. (Pubitemid 46671232)
28. Natarajan V, Jayaram HN, Scribner WM, Garcia JG. Activation of endothelial cell phospholipase D by sphingosine and sphingosine-1-phosphate. Am J Respir Cell Mol Biol 1994;11:221-229.
29. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J 2000;14:2255-2265.
30. Jang C, Koh YJ, Lim NK, Kang HJ, Kim DH, Park SK, Lee GM, Jeon CJ, Koh GY. Angiopoietin-2 exocytosis is stimulated by sphingosine- 1-phosphate in human blood and lymphatic endothelial cells. Arterioscler Thromb Vasc Biol 2009;29:401-407.
31. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM, Ye SQ, Garcia JG. Activated protein c mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 2005;280:17286-17293.
32. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 2007;115:84-105.
33. McVerry BJ, Garcia JG. In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal 2005;17:131-139.
34. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 2000;349:385-402. (Pubitemid 30465772)
35. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003;4:397-407.
36. Berdyshev EV, Gorshkova IA, Garcia JG, Natarajan V, Hubbard WC. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Anal Biochem 2005;339:129-136. (Pubitemid 40342687)
37. Singleton PA, Moreno-Vinasco L, Sammani S, Wanderling SL, Moss J, Garcia JG. Attenuation of vascular permeability by methylnaltrexone: role of MOp-r and S1P3 transactivation. Am J Respir Cell Mol Biol 2007;37:222-231.
38. Gon Y, Wood MR, Kiosses WB, Jo E, Sanna MG, Chun J, Rosen H. S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF. Proc Natl Acad Sci USA 2005;102:9270-9275.
39. Shikata Y, Birukov KG, Birukova AA, Verin A, Garcia JG. Involvement of site-specific Fak phosphorylation in sphingosine-1 phosphate - and thrombin-induced focal adhesion remodeling: role of Src and Git. FASEB J 2003;17:2240-2249.
40. Shikata Y, Birukov KG, Garcia JG. S1p induces FA remodeling in human pulmonary endothelial cells: role of Rac, Git1, Fak and Paxillin. J Appl Physiol 2003;94:1193-1203.
41. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 2006;72:3-11. (Pubitemid 44118390)
42. Niessen F, Furlan-Freguia C, Fernandez JA, Mosnier LO, Castellino FJ, Weiler H, Rosen H, Griffin JH, Ruf W. Endogenous EPCR/APCpar1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009;113:2859-2866.
43. Brinkmann V, Lynch KR. Fty720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr Opin Immunol 2002;14:569-575.
44. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002;296:346-349.
45. Kiuchi M, Adachi K, Tomatsu A, Chino M, Takeda S, Tanaka Y, Maeda Y, Sato N, Mitsutomi N, Sugahara K, et al. Asymmetric synthesis and biological evaluation of the enantiomeric isomers of the immunosuppressive FTY720-phosphate. Bioorg Med Chem 2005;13:425-432.
46. Chiba K, Hoshino Y, Ohtsuki M, Kataoka H, Maeda Y, Matsuyuki H, Sugahara K, Kiuchi M, Hirose R, Adachi K. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate. Transplant Proc 2005;37:102-106.